Fresenius Medical Care AG & Co KGaA (FMEG.DE)
53.09EUR
11:35am EDT
€-0.51 (-0.95%)
€51.80
€53.55
€53.57
€52.74
872,040
855,424
€60.27
€47.79
FMEG.DE
About
Overall
| Beta: | 0.24 |
| Market Cap (Mil.): | €16,448.12 |
| Shares Outstanding (Mil.): | 306.89 |
| Dividend: | 0.75 |
| Yield (%): | 1.40 |
Financials
| FMEG.DE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 17.89 | 27.60 | 34.28 |
| EPS (TTM): | 3.00 | -- | -- |
| ROI: | 8.10 | 6.88 | 18.85 |
| ROE: | 14.15 | 8.59 | 19.72 |
CORRECTED-German stocks - Factors to watch on May 20
(In May 20 item, corrects to remove Aixtron from ex-dividend section as the company did not pay a dividend for 2012)
German stocks - Factors to watch on May 20
FRANKFURT, May 20 - The DAX top-30 index looked set to open 0.6 percent higher on Monday, which is a public holiday in Germany, though the Frankfurt stock exchange is open for trading.
FMC to launch first ever share buyback on May 20
FRANKFURT, May 17 - German dialysis provider Fresenius Medical Care will begin its first ever share buyback programme on May 20, acquiring up to 385 million euros ($493.72 million) worth of its own stock.
Fresenius SE eyes small and mid-sized acquisition targets-paper
FRANKFURT, May 11 - German diversified healthcare group Fresenius SE has identified potential takeover targets costing up to 300 million euros ($389 million), Chief Executive Ulf M. Schneider told German weekly paper Euro am Sonntag.
UPDATE 1-Fresenius Medical profit below consensus on U.S. costs
FRANKFURT, April 30 - First-quarter net income at Fresenius Medical Care (FMC), the world's largest dialysis provider, dropped more than expected to $225 million on higher costs in the United States, its most important market.
BRIEF-Fresenius Medical Care shares down 4 pct after Q1 results
FRANKFURT, April 30 - Fresenius Medical Care : * Shares down 4 percent after Q1 results
Fresenius Medical Q1 net income down on U.S. healthcare cuts
FRANKFURT, April 30 - First-quarter net income at Fresenius Medical Care, the world's largest dialysis provider, dropped to a worse-than-expected $225 million, hurt by austerity measures in the United States, its most important market.
FMC to buy back shares, do away with preference shares
FRANKFURT, April 4 - Fresenius Medical Care , the world's largest dialysis group, said it would buy back shares worth as much as 385 million euros ($494.65 million) over the next six months using cash and existing loans.
FDA tells Fresenius Medical to improve dialyzer production
FRANKFURT, March 14 - Dialysis specialist Fresenius Medical Care said U.S. regulators had told it to improve the way it sterilizes certain dialyzers for filtering patients' blood.
FMC CEO sees slight decline in U.S. pay from 'rebasing'
FRANKFURT, Feb 26 - Fresenius Medical Care expects only a slight reduction in U.S. reimbursement for services and drugs it provides to its dialysis patients from a ruling expected later this year.
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Finlabo SIM Spa
|
$58.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
